Particle Sciences wins BHR nasal progesterone contract
Particle Sciences has been tasked with creating a nasal formulation of the steroid hormone progesterone that can be used to treat patients who have suffered traumatic brain injury.
Archives for November 25, 2013
Dispatches from PCT
Pfizer: Active role for patients as smartphones lead way in virtual trials
Smartphones are changing the role of the patient in clinical trials and can be used for industry success, Pfizer and technology provider firm Exco InTouch said at PCT 2013.
Merck Serono: new plant to make drugs deemed essential by China
Merck Serono has announced plans to build an $80m plant for the production of diabetes and cardiovascular drugs in China.
GSK continues investment in UK, with £25m API plant expansion
A £25m (€40.5m) investment at an API facility in Scotland will allow GSK closer control over its manufacturing network efficiency, the firm says.
UPDATE
Over-capacity and patent loss sees Pfizer & Merck shutter Puerto Rico plants
Pfizer says it intends to shutter a manufacturing facility in Puerto Rico just days after Merck & Co. announced it was reducing its footprint on the island.